Imago Rehab
Overview
Imago Rehab is a healthcare technology company focused on providing digital rehabilitation solutions primarily for stroke survivors. It was founded in 2021 and is headquartered in Woburn, Massachusetts. The company was established by Kristin Nuckols and Chrissy Glover. Specializing in home-use wearable robotics and virtual occupational therapy, Imago Rehab has raised funding to enhance its service offerings, with a significant focus on improving the recovery process for those with upper limb impairments. The company's unique approach integrates advanced technology with personalized telehealth services.
Recent Developments
- July 2024: Kristin Nuckols, co-founder and Chief Clinical Officer of Imago Rehab, received the 2024 NBCOT Innovation Award, acknowledging her innovative work in stroke rehabilitation using robotics and telehealth.
- Fundraising Activities: In 2024, Imago Rehab undertook a second round of seed capital raising, led by Safar Partners, targeting $2.5 million to expand its services and outreach. The initial tranche of this funding round was successfully closed.
- Expansion: Since its launch in 2021, Imago Rehab has broadened its operational reach to six states and plans to extend its services to 15 states by the end of 2024.
- Product Development: The company continues to innovate in wearable soft robotics aimed at enhancing therapy outcomes. A recent funding round contributes to further development and scaling of these technologies.
- Strategic Partnerships: Collaborations with leading insurers including Medicare and United Healthcare have bolstered Imago Rehab’s credibility and market reach.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2021 |
| Headquarters | Woburn, Massachusetts, USA |
| Founders | Kristin Nuckols, Chrissy Glover |
| Revenue | $107,135 in FY 2023 |
| Profits | Net loss of $1,350,533 in FY 2023 |
| Key Investors | Safar Partners, Cybernetix Ventures |
| Industry | HealthTech, Medical Devices |
| Number of Employees | 5-20 |
Early History
Imago Rehab was launched out of Harvard University in 2021, inspired by research aimed at revolutionizing stroke recovery through at-home rehabilitation solutions. Kristin Nuckols, an occupational therapist with a passion for integrating robotics into rehabilitation processes, was instrumental in its founding. The initial focus was on developing a telehealth-based platform, combining AI-driven wearables and personalized therapy, which rapidly gained attention for its innovative approach to neurological rehab. Early collaborations with Harvard's Biodesign Lab and Massachusetts General Hospital helped establish its scientific and technological credibility.
Company Profile and Achievements
Imago Rehab operates a digital health solution that combines telehealth services with wearable technology to facilitate stroke rehabilitation remotely. The business model involves providing tele-rehabilitation services, focusing on occupational, physical, and speech therapies through an integrated digital platform.
- Major Milestones:
- Launching a patented rehabilitation glove to assist stroke recovery through soft robotic technology.
- Collaborating with significant health systems and insurers to expand access to its telerehab services.
- Developing a clinician-led platform that uses AI and wearables to offer personalized, at-home therapy.
- Achievements:
- Raising significant capital, including a $250,000 seed funding round in June 2024.
- Receiving industry accolades such as the NBCOT Innovation Award, highlighting its contribution to stroke rehab.
- Technology and Innovations:
- The Imago Glove offers high-intensity rehabilitation using AI to monitor and enhance therapy sessions.
- Continuous enhancements and development of rehabilitation software and robotics.
Current Operations and Market Position
Imago Rehab is actively operating in the digital health and teletherapy market targeting stroke survivors and patients with similar neurological conditions. Its main product line includes robotic devices and a tele-rehabilitation platform aimed at improving the everyday functionality of stroke patients.
- Market Strategy: The company positions itself as a leader in integrating advanced robotics with clinical rehabilitation, emphasizing accessibility and personalization.
- Collaborations: Partnerships with insurers and healthcare providers are central to its operational strategy, enabling broader patient access and adoption.
- Growth Potential: With expansion plans into numerous states, Imago Rehab aims to capture a significant segment of the $7.9 billion U.S. stroke rehabilitation market.
Conclusion
Imago Rehab is a pioneering force in the field of digital rehabilitation, utilizing cutting-edge robotic technology and telehealth to improve patients' recovery from strokes and similar neurological conditions. With a focus on accessibility, the company’s model is transforming traditional rehabilitation approaches, making them more patient-centered and home-based. As it continues to expand and innovate, Imago Rehab is well-positioned to make significant advancements in the rehabilitation industry. Future growth will be supported by strategic funding, partnerships, and a strong commitment to technological advancement, positioning Imago Rehab for ongoing impact in the health tech sector.